SNX-2112
未知生产厂商
SNX-2112 is a heat shock protein 90 (Hsp90) inhibitor.
SNX-2112 is a heat shock protein 90 (Hsp90) inhibitor.
Blonanserin binds to and inhibits dopamine receptors D2 and D3 as well as the serotonin receptor 5-HT2A with high affinity . Blonanserin has low affinity for other dopamine and serotonin receptors as well as muscarinic, adrenergic, and histamine receptors. This reduces dopaminergic and serotonergic neurotransmission which is thought to produce a reduction in positive and negative symptoms of schizophrenia respectively.
Used for the treatment of schizophrenia .
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
